Loading…
This event has ended. Visit the official site or create your own event on Sched.
View analytic

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Friday, September 15
 

7:00am

Registration
Friday September 15, 2017 7:00am - 7:15am
TBA

7:15am

Kick-off Presentation
Speakers: Rakesh Jain, MD, MPH

Friday September 15, 2017 7:15am - 7:30am
TBA

7:30am

Innovation Theater (Non-CME): A Long-Acting Injectable (LAI) Treatment for Schizophrenia with a New Dosing Interval Option
Non-CME. Breakfast will be served. Seating is limited to 400 attendees and will be availableon a first-come, first-served basis. Please plan to arrive early to ensure a seat.Breakfast will only be available until 8 A.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Alkermes, Inc.

Friday September 15, 2017 7:30am - 8:45am
La Nouvelle Orleans C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

8:50am

Advanced Psychopharmacology Preconference: Real Patients. Real Problems. Real Solutions.
Preregistration required. Limited seating. Additional fees apply. 
Join more than 500 of your dedicated mental healthcare professional peers who are looking to further their knowledge and understanding of specialized topics in psychopharmacology. Members of the esteemed Psych Congress Steering Committee will lead case-based presentations that aim to answer some of the most difficult diagnosis and prescribing questions that even the most experienced practitioners find challenging.

Speakers
avatar for Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APN

Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APN

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Nursing University of Illinois at Chicago | | Julie Carbray holds her PhD and Master of Science degrees from Rush University, Chicago and her Bachelor of Science degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois at Chicago (UIC), she has been on faculty at UIC since 1993. As the Administrative Director of the Pediatric Mood Disorder Program, Dr. Carbray manages the clinical programs and multidisciplinary training for the clinic and is a clinical expert in the area of children and adolescents with mood disorders within the UIC Depression and Resilience Center. As a clinician, Dr. Carbray has a national reputation of excellence in serving families of children with mood disorders, and was recognized by the UIC community in 2008 by receiving the Karen Gousman Excellence in Nursing Award and the American Psychiatric Nurses... Read More →
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Psych Congress Steering Committee Member; Private Practice, Austin, Texas; Adjunct Clinical Affiliate, School of Nursing, University of Texas at Austin, Austin, Texas | | Saundra Jain, MA, PsyD, LPC, provides workshops to healthcare practitioners, organizations, businesses, and individuals interested in learning more about the power of wellness. In 1992, Dr. Jain launched a private practice of psychotherapy, where she currently provides services for a wide range of mental health issues. | | Dr. Jain is very active in the area of peer-to-peer education, especially in the disease states of depression, bipolar disorder, anxiety disorders, and ADHD. Another strong clinical and educational interest involves differential diagnosis of major psychiatric disorders. She is the co-creator and co-presenter of a novel and extremely well-received interactive workshop/program addressing the challenges of dealing with psychiatric comorbidities through the use of psychiatric scales and screeners. This program reached a national audience, and according to many attendees changed the way they practice medicine. Dr. Jain has been instrumental in developing several other innovative tools/programs to fill current gaps in this area. She is the co-creator and co-presenter featured on an interactive DVD titled Differentiating Bipolar Depression from Unipolar Depression. Recently, Dr. Jain served as the co-host... Read More →
avatar for Charles Raison, MD

Charles Raison, MD

Psych Congress Co-Chair; Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin | | Charles L. Raison, MD, is the Mike and Mary Sue Shannon Endowed Chair in Mind, Body, and Family Well-being, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, Wisconsin. Prior to this he was Professor in the Department of Psychiatry, College of Medicine, and the Barry and Janet Lang Professor of Integrative Mental Health at the Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona. | Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. In 2014 Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Psych Congress Co-Chair; Clinical Professor, Department of Psychiatry,Texas Tech Health Sciences Center, School of Medicine, Midland, Texas | | Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India and attended graduate school at the University of... Read More →
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina | | Vladimir Maletic, MD, MS, is a clinical professor of neuropsychiatry and behavioral science at the U... Read More →


Friday September 15, 2017 8:50am - 4:30pm
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

12:10pm

Innovation Theater (Non-CME): A Discussion of the Science and Clinical Decision-Making Behind Bipolar Depression Diagnosis
Non-CME. Lunch will be served. Seating is limited to 400 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:40 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Sunovion Pharmaceuticals Inc.

Friday September 15, 2017 12:10pm - 1:25pm
La Nouvelle Orleans C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

4:30pm

Kickoff Keynote Address — Neurocognition of Food: Culinary Medicine and the Role of Food in Psychiatry
Join Psych Congress for an educational and appetizing kickoff keynote address that will feature New Orleans' own Timothy Harlan, MD, FACP, Executive Director of the Goldring Center for Culinary Medicine, and Associate Professor of Medicine at Tulane University.

In his CME-accredited address and cooking demonstration, Dr. Harlan will be discussing the negative impact the standard American diet has on psychotic disorders. Attendees will learn about foods shown to promote optimal brain function and understand the role of diet in ADHD, as well as recognize how modern diets contribute to increasing rates of dementia.

CME Accredited. Limited seating. Must be registered for Psych Congress to attend.  

Speakers
avatar for Timothy S. Harlan, MD, FAPC

Timothy S. Harlan, MD, FAPC

Assistant Dean for Clinical Services, Tulane University; Executive Director, Goldring Center for Culinary Medicine | | “Eating well and eating healthy is the same thing," says Timothy Harlan, MD, aka “Dr. Gourmet,” who discovered his love of food long before embarking on a successful career as a physician. By the age of 18, Dr. Harlan was managing his rst restaurant and opened an intimate French Bistro at age 22. Returning to school to pursue a degree in Hotel and Restaurant Management, Dr. Harlan found his way to medicine. While completing his degree, he began writing about the clear link between food and health, blending his extensive knowledge of food and nutrition with his medical expertise. Dr. Harlan is the Executive Director of The Goldring Center for Culinary Medicine (GCCM) at Tulane University. GCCM is part of an innovative program at Tulane Univer- sity that requires medical students to work in the nation's rst medical school teaching kitchen to gain a real-world understanding of diet and lifestyle in a setting that bridges the gap between basic sciences, clinical medicine, the community and culinary education. GCCM's unique curriculum has currently been adopted by over 20% of medical schools in the U.S., ensuring that future clinicians have greater knowledge of and appreciation for the vital role nutrition plays in overall... Read More →
avatar for Leah Sarris, RD, LDN

Leah Sarris, RD, LDN

Director of Operations/Executive Director, Instructor of Medicine | | Leah Sarris is the Program Director for the Goldring Center for Culinary Medicine at Tulane University in New Orleans. She is thought to be the first chef employed full time by a medical school. Chef Leah obtained her BS in Culinary Nutrition from the prestigious Johnson... Read More →


Friday September 15, 2017 4:30pm - 6:00pm
La Nouvelle Orleans C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

6:15pm

Disrupting Mental Illness: Advancing Technologies, Improving Lives (Non-CME)
Despite the immense potential for technologies to "disrupt" mental illness, too few viable solutions have made it into the hands of those who need them most. To spur innovation and bridge the gap between the technology community and the mental health community, Otsuka America Pharmaceutical, Inc. is hosting a first-of-its-kind Live Pitch Event. This Pitch Event will bring together an exclusive group of promising technologists to showcase their new innovations to the mental health community. Each group of entrepreneurs will have an opportunity to deliver a short pitch before a panel of expert judges made up of mental health professionals, venture capitalists, and industry representatives, as well as those living with mental illness and their supporters. Following the short pitches by each team, the judges will select a winner. The Pitch Event is sponsored by Otsuka America Pharmaceutical, Inc. in conjunction with Psych Congress.

Limited seating. Pre-registration is required.  

Friday September 15, 2017 6:15pm - 8:30pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130
 
Saturday, September 16
 

7:30am

Relishing the Past and Welcoming the Future: Examining Psychiatry's Recent and Future Breakthroughs

Psych Congress is turning 30, and to celebrate that, we are looking back to see how far psychiatry has come since the meeting started, as well as looking toward the future to see what is in store for the next 30 years. Join the co-Chairs, Drs. Jain and Raison, as they review the most notable developments in psychiatry and speculate what mental health treatment could look like in the future.


Speakers
avatar for Charles Raison, MD

Charles Raison, MD

Psych Congress Co-Chair; Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin | | Charles L. Raison, MD, is the Mike and Mary Sue Shannon Endowed Chair in Mind, Body, and Family Well-being, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, Wisconsin. Prior to this he was Professor in the Department of Psychiatry, College of Medicine, and the Barry and Janet Lang Professor of Integrative Mental Health at the Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona. | Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. In 2014 Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Psych Congress Co-Chair; Clinical Professor, Department of Psychiatry,Texas Tech Health Sciences Center, School of Medicine, Midland, Texas | | Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India and attended graduate school at the University of... Read More →


Saturday September 16, 2017 7:30am - 8:45am
La Nouvelle Orleans A - C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:00am

New Developments in the Treatment of Social Anxiety Disorder

This session will review new developments in social anxiety disorder (SAD), focusing on state-of-the-art pharmacologic and psychotherapy treatments. Dr. Schneier will also review diagnosis and comorbidities, and will describe future directions in SAD research.


Speakers
avatar for Franklin R. Schneier, MD

Franklin R. Schneier, MD

Co-Director, Anxiety Disorders Clinic, New York State Psychiatric Institute; Special Lecturer in Psychiatry, Columbia University Medical Center | | Franklin Schneier, MD, is a graduate of Yale College and Cornell University Medical College, and completed his residency in psychiatry at Mt. Sinai Medical Center. Dr. Schneier is currently Co-Director of the Anxiety Disorders Clinic at NY State Psychiatric Institute and a Special Lecturer at Columbia University Medical Center, where his clinical research has been continuously funded by the National Institutes of Health for over 25 years. Dr... Read More →


Saturday September 16, 2017 9:00am - 10:15am
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:00am

New Developments in Our Thinking about Personality Disorders

Within the last few years, progress has been made in our understanding of personality disorders (PDs). The essential dimensional nature of PDs has been recognized for decades, yet our diagnostic terminology continues to be based on categorical disease-based definitions. However, an Alternative Model for DSM-5 Personality Disorders (AMPD) was developed that is included in Section III of DSM-5—the section for “Emerging Measures and Models.” Dr. Oldham was Co-Chair of the Work Group that developed the model and will describe the model and summarize the substantial body of new research focusing on this new step in a dimensional direction for PDs.


Speakers
avatar for John Oldham, MD, MS

John Oldham, MD, MS

Professor of Psychiatry, Baylor College of Medicine, Houston, Texas | | John M. Oldham, M.D. is currently Professor of Psychiatry at Baylor College of Medicine, and he holds the Barbara and Corbin J. Robertson, Jr. Endowed Chair for Personality Disorders. Dr. Oldham is Secretary- General of the American College of Psychiatrists (ACP) and is Past President of the American Psychiatric Association (APA), the ACP, the New York County District Branch of the APA, the South Carolina Psychiatric Association, the International Society for the Study of Personality Disorders, and... Read More →


Saturday September 16, 2017 9:00am - 10:15am
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

9:00am

Solving Clinical Challenges in Major Depression

“Solving Clinical Challenges” addresses complex conundrums that are faced by Psych Congress attendees in managing their patients with major depression. Dr. Thase will discuss and respond to real cases and real issues from attendees who were surveyed prior to the conference. Challenges that may be covered include: 1) diagnostic nosology, accurate diagnosis, and screening; 2) pharmacologic treatments; 3) side effect management; and 4) non-pharmacologic treatments.


Speakers
avatar for Michael E. Thase, MD

Michael E. Thase, MD

Professor of Psychiatry, Perelman School of Medicine University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania | | Michael E. Thase, MD, joined the faculty of the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania, in January, 2007 as a Professor of Psychiatry and Director of the Department of... Read More →


Saturday September 16, 2017 9:00am - 10:15am
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:00am

The Truth About Shared Decision Making

While most mental health professionals believe they are engaging in shared decision making, they may be unaware of aspects of the power differential that can impact patients. This session will familiarize attendees with the concept and practice of shared decision making (SDM). Dr. Velligan will review pre-existing preferences and cognitive appraisal biases that complicate decision-making for patients and caregivers. New models of SDM that take into account both doctor and patient behaviors necessary for success will also be presented.


Speakers
avatar for Dawn I. Velligan, PhD

Dawn I. Velligan, PhD

Professor, Chief Division of Community Recovery, Research and Training, Henry B. Dielmann Chair, Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas | | Dawn I. Velligan, PhD, is a professor in the Department of Psychiatry, Chief of the Division of Community Recovery, Research and Training, and Henry B. Dielmann Chair at the University of Texas Health Science Center in San Antonio, Texas. Dr... Read More →


Saturday September 16, 2017 9:00am - 10:15am
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:30am

ADHD and Substance Use Disorders: An Intoxicating Combination

Despite a growing literature on the life course of attention-deficit/hyperactivity disorder (ADHD), a comprehensive understanding of one of the most feared outcomes, substance use disorders (SUD), is lacking. Moreover, many adolescents and adults with SUD may have undiagnosed and untreated ADHD. Dr. Wilens will discuss the relationship of ADHD and SUD across the lifespan. Data on prevention of SUD in ADHD individuals growing up will be presented. Treatment strategies including psychotherapy and/or medication treatment in individuals with comorbid ADHD and SUD will be presented, along with recent data about stimulant misuse and diversion.


Speakers
avatar for Timothy Wilens, MD

Timothy Wilens, MD

Chief, Child and Adolescent Psychiatry, Co-Director, Center for Addiction Medicine, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School | | Timothy E. Wilens, MD, is Chief of the Division of Child and Adolescent Psychiatry, and Co-Director of the Center for Addiction Medicine at the Massachusetts General Hospital in Boston, Massachusetts. Dr. Wilens specializes in the diagnosis and treatment of substance use disorders, bipolar disorder, and Attention Deficit Hyperactivity Disorder (ADHD). Widely published, Dr. Wilens has more than 350 original articles, reviews, chapters, books, and editorials to his credit. Dr. Wilens is a consultant on ADHD and substance use disorders to Phoenix House and Bay Cove Human services, as well as the National Football League and Major... Read More →


Saturday September 16, 2017 10:30am - 11:45am
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

10:30am

Navigating the Nuances of Mood Disorders Diagnosis

Current practice environments demand that mental health professionals complete new diagnostic evaluations with more frequency, skill, and savvy, and often across lifespan and diagnostic neighborhoods. The DSM-5 has changed the approach to diagnosis of mood disorders across the lifespan, leaving clinicians with questions as to how to best address complexities such as mixed states, rapid cycling, and differential diagnosis. This session will use clinical cases to synthesize complex patient symptoms with diagnostic criteria, integrating diagnostic tools and tips for educating patients about their diagnosis and the diagnostic process.


Speakers
avatar for Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APN

Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APN

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Nursing University of Illinois at Chicago | | Julie Carbray holds her PhD and Master of Science degrees from Rush University, Chicago and her Bachelor of Science degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois at Chicago (UIC), she has been on faculty at UIC since 1993. As the Administrative Director of the Pediatric Mood Disorder Program, Dr. Carbray manages the clinical programs and multidisciplinary training for the clinic and is a clinical expert in the area of children and adolescents with mood disorders within the UIC Depression and Resilience Center. As a clinician, Dr. Carbray has a national reputation of excellence in serving families of children with mood disorders, and was recognized by the UIC community in 2008 by receiving the Karen Gousman Excellence in Nursing Award and the American Psychiatric Nurses... Read More →
avatar for Mani Pavuluri, MD, PhD

Mani Pavuluri, MD, PhD

Professor and Founding Director, Pediatric Mood Disorders Program, University of Illinois, Chicago, Illinios | | Mani Pavuluri, MD, PhD, is the Distinguished Fellow at the American Academy of Child and Adolescent Psychiatry, Fellow of Royal Australian and NZ College of Psychiatrists, Fellow of the American College of Neuropsychopharmacology, Professor at the Department of Psychiatry, University of Illinois at Chicago, and the Founding Director of the Pediatric Mood Disorders Program. Dr. Pavuluri is the co-founder and strategic advisor for the digital company Medcircle Inc., a health education network. Dr. Pavuluri has the collective vision to serve in the public sector at the University of Illinois, nonprofit sector at drmanipavuluri.com, and the private sector at MedCircle Inc. | Dr. Pavuluri was endowed the Berger-Colberth Team Chair in Child Psychiatry in 2010. Dr. Pavuluri completed her psychiatric training in NZ, Australia and USA, board-certified in both General Psychiatry and Child and Adolescent Psychiatry. She is named as Best Doctor, Top Doctor, and Top Psychiatrist by her peers and consumers in USA. Dr. Pavuluri has received prestigious national prizes such as the Klerman award for the best scientific discovery, AACAP Klingenstein prize for the best paper on mood disorders, and the University Scholar of the Year Award at the University of Illinois. She won the Jay Hirsch Excellence in Teaching Award from UIC Child Psychiatry Fellows. Dr. Pavuluri serves on editorial boards of international scientific journals. She has mentored many clinical and research faculty and their programs across the world and consults patients from 33 states in the USA. Her scientific work is a trailblazer for the understanding of brain circuitry function and medication effects on brain function in mood disorders such as bipolar disorder and ADHD through functional magnetic neuroimaging technology (fMRI). Her research has been funded by federal and leading private foundations. Dr... Read More →


Saturday September 16, 2017 10:30am - 11:45am
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:30am

Suicide Risk Assessment and Malpractice Prevention

Suicide is the leading cause of mental health malpractice. The Joint Commission noted that insufficient patient assessment is the root cause in over 80% of suicidal deaths. One-half of inpatient suicides result in a lawsuit. This session will provide the latest research on risk and protective factors for suicide. Persons who have decided to commit suicide view their therapist as adversaries rather than allies. The implications of this for assessment of suicidal patients will be delineated.


Speakers
avatar for Phillip J. Resnick, MD

Phillip J. Resnick, MD

Professor of Psychiatry, Case Western Reserve University | Philip Resnick, MD, served as a consultant in many high-profile cases, including those of Jeffrey Dahmer, Susan Smith, Timothy McVeigh, Andrea Yates, Scott Peterson, Casey Anthony, Theodore Kaczynski, the Unabomber, and... Read More →


Saturday September 16, 2017 10:30am - 11:45am
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:30am

Has Asperger's Disorder Died?

Many people have been diagnosed with Asperger’s disorder, and the world has been comfortable with this term. Despite the removal of Asperger’s disorder from the DSM-5 and inclusion now as autism spectrum disorder, is the term Asperger’s syndrome gone? There is considerable difficulty for patients and families to accept the new category and the loss of a distinct personality type. This session will provide some thought provoking points of view about why it may live on, despite the DSM-5.


Speakers
avatar for Doris Greenberg, MD

Doris Greenberg, MD

Developmental and Behavioral Pediatrician; Associate Clinical Professor of Pediatrics, Mercer University School of Medicine, Savannah, Georgia | | Doris M. Greenberg, MD is a Developmental and Behavioral Pediatrician in Savannah, Georgia.  Dr. Greenberg is an Associate Clinical Professor of Pediatrics for the Mercer University School of Medicine, and she teaches Developmental Pediatrics to residents in Family Medicine and Pediatrics at the Memorial University Medical Center in Savannah, Georgia. She was educated at Cornell University College of Arts and Sciences for her BA degree, she received her MD degree at Albany Medical College, and she interned in Boston City Hospital... Read More →


Saturday September 16, 2017 10:30am - 11:45am
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

12:00pm

Innovation Theater (Non-CME): A Development in ADHD: Presenting a Treatment Option for Adults
Non-CME. Lunch will be served. Seating is limited to 1,000 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:30 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Shire.

Saturday September 16, 2017 12:00pm - 1:30pm
La Nouvelle Orleans A - C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

1:45pm

Advancing the Long-Term Management of Substance Use Disorders Through Medication-Assisted Treatment Strategies

The prevalence of SUDs is rising dramatically, with rates as high as 17 million for alcohol use disorder (AUD) and over 2 million for opioid use disorder (OUD). More than 100 American deaths per day are attributable to OUD alone. Despite available treatments, SUDs remain undertreated, perpetuating poor patient outcomes. This session will examine the latest research and evidence surrounding SUD treatment advances, including differences among oral and depot formulations, efficacy of available options within long-term management, implications on patient adherence, potential for illicit diversion, and associated genetic predilections to treatment response. In addition, as it is common for SUDs to co-exist with psychiatric disorders, evidence-based strategies for addressing concomitant SUD and other psychiatric disorders will be explored.

Supported by an educational grant from Alkermes, Inc. 


Speakers
avatar for Roger Weiss, MD

Roger Weiss, MD

Professor of Psychiatry, Harvard Medical School, Boston, Massachusetts; Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts | | Roger D. Weiss, M.D., is Professor of Psychiatry at Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse at McLean Hospital in Belmont, Massachusetts. Dr... Read More →


Saturday September 16, 2017 1:45pm - 3:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

1:45pm

A Review of the Science and Practical Applications of TMS

Transcranial magnetic stimulation (TMS) remains an emerging science and a treatment modality that few fully understand, and it remains underutilized. This session will review the history and scientific underpinnings of transcranial magnetic stimulation (TMS), as well as review the new literature available from the last 12 months for the busy clinician.


Speakers
avatar for Jon W. Draud, MD, MS

Jon W. Draud, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry, University of Tennessee College of Medicine, Memphis, Tennessee; Medical Director of Psychiatry, Pain Management Group, Trust Point Psychiatric Hospital, St. Thomas Rutherford Hospital; Medical Director... Read More →


Saturday September 16, 2017 1:45pm - 3:00pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

1:45pm

Obsessive-Compulsive Disorder: Treatment with Psychotherapy and Pharmacotherapy

Obsessive-compulsive disorder (OCD) is a common and disabling illness. Research suggests that most clinicians do not know how to properly diagnose and treat OCD. This session will describe how to diagnose OCD, understand its clinical presentations, and develop an evidence-based approach to treatment using psychotherapy and medications.


Speakers
avatar for Jon Grant, MD, JD, MPH

Jon Grant, MD, JD, MPH

Professor, Department of Psychiatry & Behavioral Neuroscience, University of Chicago | | Jon E. Grant, JD, MD, MPH, is a Professor of Psychiatry and Behavioral Neuroscience at the University of Chicago, Illinois, where he also supervises an outpatient clinic for addictive-impulsive-compulsive disorders. Dr. Grant is the author of 12 books on impulsive and compulsive behaviors and over 300 peer-reviewed scientific articles. Dr. Grant is the Director of the Center of Excellence in Gambling Research, supported by the National Center for Responsible Gaming, and Editor-in-Chief of... Read More →


Saturday September 16, 2017 1:45pm - 3:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

3:15pm

Aging, Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer’s Disease

Traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE) are commonly seen on the news and featured in public media. Falls are the leading cause of TBI in the elderly worldwide, while CTE is a growing hazard often linked to repetitive mild concussions to the brain, often starting in childhood with exposure to violent sports. TBI is a risk factor in older adults for Alzheimer’s disease (AD), and CTE is a risk factor for early AD, Parkinson’s disease, and even suicide. This session will focus on prevalence, pathophysiology, symptoms, and treatment of TBI and CTE and their unique relationship to aging and AD.


Speakers
avatar for George Grossberg, MD

George Grossberg, MD

Samuel W. Fordyce Professor, Director, Division of Geriatric Psychiatry, Department of Psychiatry and Behavioral Neuroscience, St. Louis University School of Medicine | George T. Grossberg, MD, completed his medical degree at the St. Louis University School of Medicine in Missouri. His postdoctoral training included an internship at St. John's Mercy Medical Center and a residency in the St. Louis University Department of Psychiatry. A Diplomate of the National Board of Medical Examiners and a Distinguished Fellow of the American Psychiatric Association, Dr. Grossberg holds membership in several professional societies. Additionally, he started the first Geriatric Psychiatry program in Missouri, as well as the first... Read More →


Saturday September 16, 2017 3:15pm - 4:30pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

3:15pm

Examining the Limitations of Monoamine-Directed Therapy in Major Depressive Disorder: Novel Mechanisms and Treatment Targets

Recent research into the pathophysiology of MDD is revealing novel treatment targets that go beyond monoamines and include other targets, such as glutamate neurotransmission (e.g. ketamine and other modulators); modulation of cholinergic and gamma-aminobutyric acid (GABA)-ergic transmission; neuronal plasticity; stress/hypothalamic pituitary adrenal (HPA)-axis; neuroinflammation; and the reward system via modulation of opioid receptors and beta endorphins. In this session, Dr. Maletic will compare the safety and efficacy of novel MDD agents and their complementary role within the current treatment armamentarium.

Supported by an educational grant from Alkermes, Inc. 


Speakers
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina | | Vladimir Maletic, MD, MS, is a clinical professor of neuropsychiatry and behavioral science at the U... Read More →


Saturday September 16, 2017 3:15pm - 4:30pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

3:15pm

How Changing Cannabis Policies Will Affect Your Practice

As of January 2017, 28 states and Washington, DC have implemented medical cannabis policies, and nine states and Washington, DC have legalized recreational cannabis. As more states consider medical cannabis and recreational cannabis policies, mental health professionals are left to wonder about the effects of these policies on their practices. Dr. Hill will take an evidence-based look at the impact of cannabis policies in the states that have implemented them with an eye to the future.


Speakers
avatar for Kevin Hill, MD, MHS

Kevin Hill, MD, MHS

Assistant Professor of Psychiatry, McLean Hospital, Harvard Medical School | Kevin Hill, MD, MHS, is an Assistant Professor of Psychiatry at McLean Hospital and Harvard Medical School and Director of McLean’s Substance Abuse Consultation Service. Dr. Hill earned a Master’s in Health Science at the Robert Wood Johnson Clinical Scholars Program at the... Read More →


Saturday September 16, 2017 3:15pm - 4:30pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

4:45pm

Connecting Music to Mental Health

Back by popular demand, 2015 Keynote Speaker Vijay Gupta, MM, will explore the connection between music and mental health, explaining why music’s redemptive power may hold more potential than we realize. Mr. Gupta draws from his work as director of Street Symphony — a classical musical outreach non-profit organization — to illustrate how music can bring people back from the brink of their darkest times. The presentation will include a performance by Mr. Gupta and members of his Street Symphony. This is a featured session you don’t want to miss.


Speakers
avatar for Vijay Gupta, MM

Vijay Gupta, MM

Founder/Artistic Director of Street Symphony, Los Angeles, California; Violinist | | A critically acclaimed musician, Mr. Gupta joined the Los Angeles Philharmonic at the age of 19 and made his solo debut at age 11 with the Israel Philharmonic under Zubin Mehta. He has a Master&rsquo... Read More →


Saturday September 16, 2017 4:45pm - 5:45pm
La Nouvelle Orleans A - C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

6:00pm

Opening Night Reception in the Exhibit Hall
Saturday September 16, 2017 6:00pm - 7:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

7:45pm

Psych Congress 30th Anniversary Celebration
Ring in Psych Congress' 30th anniversary with a Mardi Gras-themed celebration at nearby Mardi Gras World. Join faculty and friends as you wander through the elaborate float den, listen to live jazz music, enjoy the local food and drink, and so much more! 

Tickets for the anniversary celebration will be limited to the first 500 people. 

Saturday September 16, 2017 7:45pm - 9:45pm
Mardi Gras World: The New Orleans Mardi Gras Museum 1380 Port of New Orleans Pl, New Orleans, LA 70130
 
Sunday, September 17
 

7:00am

Industry-Supported Symposia: Advances in the Management of Tardive Dyskinesia
Breakfast will be served. Seating for these sessions is available on a first-come, firstservedbasis. Admittance is based on availability and is not guaranteed. Please plan toarrive early to ensure a seat. Breakfast will only be available until 8 A.M.

Research into tardive dyskinesia (TD) pathophysiology and treatment targetshas led to the advancement of vesicular monoamine transporter 2 (VMAT2)inhibitors, with one agent recently approved by the FDA and the other grantedbreakthrough therapy designation. Key differences in the pharmacokinetic/pharmacodynamic properties of these newer agents will be examined, as wellas clinical outcome data from the ARM-TD, AIM- TD, KINECT-3, the ongoingKINECT-4, and other clinical trials.

Supported by an educational grant from Teva Pharmaceuticals.

Sunday September 17, 2017 7:00am - 9:00am
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

7:00am

Industry-Supported Symposia: Tackling the Spectrum of Symptom Domains in Schizophrenia: Tailoring Treatment to Address Patient Needs
Breakfast will be served. Seating for these sessions is available on a first-come, firstservedbasis. Admittance is based on availability and is not guaranteed. Please plan toarrive early to ensure a seat. Breakfast will only be available until 8 A.M.

Among the spectrum of mental health conditions, schizophrenia presents considerablechallenges in clinical management. Within schizophrenia, treatmentis not aligned with evolving best practices that now rank negative, cognitive,and mood symptomatology on par with classic positive symptoms. Many conventionalantipsychotic pharmacotherapies mainly address positive symptomsand are associated with adverse effects, contributing to incomplete treatmentand poor adherence. In this session, Drs. Citrome and Correll will identify thelimits of conventional schizophrenia pharmacotherapies in addressing thespectrum of symptom domains and tolerability in consideration for individualizedtreatment plans.

Supported by an educational grant from Allergan, Inc.

Sunday September 17, 2017 7:00am - 9:00am
La Nouvelle Orleans C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Preparing for Unplanned Pregnancies in Your Practice: What you Need to know

Women of reproductive age are often treated for psychiatric disorders and are on maintenance treatment. Approximately 50% of pregnancies in the United States are unplanned. Dr. Freeman will discuss the considerations for stopping or continuing different pharmacologic treatments during pregnancy for common psychiatric disorders, including mood disorders, anxiety disorders, attention-deficit/hyperactivity disorder, and psychotic disorders. 


Speakers
avatar for Marlene Freeman, MD

Marlene Freeman, MD

Associate Professor of Psychiatry, Harvard Medical School; Associate Director, Perinatal and Reproductive Psychiatry, Massachusetts General Hospital; Medical Director, Clinical Trials Network and Insitute, Massachusetts General Hospital, Boston, Massachusetts  | Marlene P. Freeman, MD, is an Associate Professor of Psychiatry at Harvard Medical School. Dr. Freeman is the Associate Director of the Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital (MGH) and the Medical Director of the MGH Clinical Trials Network and Institute. Dr. Freeman completed medical school at Northwestern University Medical School. She completed her residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. Her research and clinical expertise are in the areas of mood disorders and... Read More →


Sunday September 17, 2017 9:15am - 10:30am
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Solving Clinical Challenges in Bipolar Disorder

“Solving Clinical Challenges” addresses complex conundrums that are faced by Psych Congress attendees in managing their patients with bipolar disorder. Dr. Ketter will discuss and respond to real cases and real issues from attendees who were surveyed prior to the conference. Challenges that may be covered include: 1) diagnostic nosology, accurate diagnosis, and screening; 2) pharmacologic treatments; 3) side effect management; and 4) non-pharmacologic treatments.


Speakers
avatar for Terence A. Ketter, MD

Terence A. Ketter, MD

Professor Emeritus, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California | | Since 1995, Terence Ketter, MD, has been a Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, as well as the founder and Chief of... Read More →


Sunday September 17, 2017 9:15am - 10:30am
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Advances in Understanding and Treating Autism Spectrum Disorders

Major advances in our understanding of autism spectrum disorders and their treatments have occurred in the last several years. This session will provide an overview of autism and related disorders, including new developments in diagnosis, treatment, and changes in outcome with earlier intervention. Common comorbid conditions will be discussed and treatment strategies summarized. Our increased understanding of the neural and genetic mechanisms underlying autism will be reviewed. 


Speakers
avatar for Fred R. Volkmar, MD

Fred R. Volkmar, MD

Irving B. Harris Professor, Yale University, New Haven, Connecticut | | Fred R. Volkmar, MD, is the Irving B. Harris Professor of Child Psychiatry, Pediatrics, and Psychology at the Yale University Child Study Center, School of Medicine. Four years after completing his residency at Stanford, Dr. Volkmar received a Fellowship in Child Psychiatry at Yale... Read More →


Sunday September 17, 2017 9:15am - 10:30am
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Overcoming the 7 Common Perils of Telepsychiatry

Telepsychiatry is reaching maturity as a field, and increasingly is being used in both individual providers and organizations to increase both the quality and availability of mental healthcare, particularly for underserved populations. This session will educate mental health professionals about the 7 most common and critical issues in developing, administering, and providing clinical telepsychiatry services. These “7 perils” include navigating regulatory issues; developing fiscally sustainable services/programs; building an effective virtual team; attending to the interface of cultural and technology; handling psychiatric emergencies; management of the virtual doctor-patient relationship; and growing services beyond a pilot clinic. Dr. Shore will focus on identifying key issues related to these perils, and pragmatic approaches to successfully addressing these challenges.


Speakers
avatar for Jay Shore, MD, MPH

Jay Shore, MD, MPH

Director of Telemedicine, Helen and Arthur E. Johnson Depression Center, University of Colorado Anschutz Medical Campus | | Jay Shore, MD, MPH, has focused on leveraging technology and specifically telepsychiatry for increasing access and quality of care for Native, Military and... Read More →


Sunday September 17, 2017 9:15am - 10:30am
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Postpartum Mood Disorders

Postpartum mood disorders include postpartum depression, postpartum bipolar episodes, and postpartum psychosis, which is usually an affective disorder. Postpartum anxiety must also be considered, as it is extremely common for postpartum women to experience anxiety, and they are at particularly high risk of obsessive symptoms. In this session, Dr. Freeman will discuss presentation and risk factors for these disorders, treatment considerations, and breastfeeding and sleep considerations.


Speakers
avatar for Marlene Freeman, MD

Marlene Freeman, MD

Associate Professor of Psychiatry, Harvard Medical School; Associate Director, Perinatal and Reproductive Psychiatry, Massachusetts General Hospital; Medical Director, Clinical Trials Network and Insitute, Massachusetts General Hospital, Boston, Massachusetts  | Marlene P. Freeman, MD, is an Associate Professor of Psychiatry at Harvard Medical School. Dr. Freeman is the Associate Director of the Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital (MGH) and the Medical Director of the MGH Clinical Trials Network and Institute. Dr. Freeman completed medical school at Northwestern University Medical School. She completed her residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. Her research and clinical expertise are in the areas of mood disorders and... Read More →


Sunday September 17, 2017 10:45am - 12:00pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Opioid Dependence: The Crossroads Between Pain and Addiction

The opioid epidemic is the most significant current problem in the medical community, yet we get little education on treatment. We have patients that are in pain and require opioids for treatment, and some will transition into opioid addiction. Dr. Podesta will discuss some alternatives and ways to screen and treat this population, and discuss rational prescribing of partial opioid agonists. 


Speakers
avatar for Arwen Podesta, MD, ABPN, FASAM, ABIHM

Arwen Podesta, MD, ABPN, FASAM, ABIHM

Assistant Professor of Psychiatry, Tulane University; Medical Director, Odyssey House Louisiana; Medical Director, ACER LLC; Medical Director, Dependency Pain Treatment Centers; Owner/Psychiatrist, Podesta Wellness | | Arwen Podesta, MD, is a board-certified adult psychiatrist with sub-specializations in addiction medicine, forensic psychiatry, and integrative... Read More →


Sunday September 17, 2017 10:45am - 12:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Love is a Drug: Clinical Relevance of Early Life Adversity and Relationship Disturbances

Early life adversity and relationship disturbances significantly influence presentation of psychiatric disorders and their treatment outcomes. In addition to contributing to disease vulnerability and psychopathology, early life adversity and relationship disturbances also precipitate a host of autonomic, endocrine, and immune perturbations. Our goal is to increase awareness of these important clinical issues and promote appropriate treatment interventions.


Speakers
avatar for Bernadette DeMuri, MD

Bernadette DeMuri, MD

Clinical Professor, Medical College of Wisconsin; Medical Director, Associated Mental Health Consultants; The TMS Center of Wisconsin, Milwaukee, Wisconsin | Bernadette DeMuri, MD, received her medical degree from the Medical College of Wisconsin and completed residencies in bo... Read More →
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina | | Vladimir Maletic, MD, MS, is a clinical professor of neuropsychiatry and behavioral science at the U... Read More →


Sunday September 17, 2017 10:45am - 12:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Connected Health Technologies and Mobile Apps for Mental Health

New consumer and digital health technologies have proliferated, covering a wide variety of disorders such as depression, anxiety, eating disorders, and even addictions. However, the quality of these apps is variable, as little to no regulation exists. Consumer apps and devices do not have the same robust efficacy and safety studies as FDA-approved treatments. Despite this, clinicians have an opportunity to incorporate these connected health technologies into their practice and prepare for future consumer technologies. Dr. Chan will discuss how to critically evaluate tools for use and implementation in clinical practice. 


Speakers
avatar for Steven Chan, MD, MBA

Steven Chan, MD, MBA

Clinical Informatics Fellow, University of California San Francisco | | Steven Chan, MD, MS (@StevenChanMD) works at the intersection of healthcare, behavior, medicine, business, and technology. Dr. Chan not only reports on the latest technology trends as Associate Editor of iMedicalApps.com... Read More →


Sunday September 17, 2017 10:45am - 12:00pm
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theater (Non-CME): Beyond Childhood: Recognizing ADHD in Adults
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Shire.

Sunday September 17, 2017 12:15pm - 1:30pm
Room 255 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theater (Non-CME): IN PLAIN VIEW: Exploring a Once-Monthly LAI Treatment Option
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck LLC.

Sunday September 17, 2017 12:15pm - 1:30pm
Room 252 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theater (Non-CME): New Treatment for Tardive Dyskinesia: A Case-Based Approach
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Neurocrine Biosciences, Inc.

Sunday September 17, 2017 12:15pm - 1:30pm
Room 356 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theater (Non-CME): Recognizing and Treating Major Depressive Disorder
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Takeda Pharmaceuticals U.S.A., Inc. & Lundbeck.

Sunday September 17, 2017 12:15pm - 1:30pm
Room 353 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Exhibit Hall and Poster Pavilion
Sunday September 17, 2017 12:15pm - 2:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

12:30pm

Product Showcase: Genomind: Your Mental Health Partner in the Era of Personalized Medicine

Speaker: Michelle Cochran, MD

Presented by Genomind 


Sunday September 17, 2017 12:30pm - 1:00pm
Theater #1 in Exhibit Hall D The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

1:30pm

Psych Congress Network Live!
Sunday September 17, 2017 1:30pm - 2:00pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

1:30pm

Poster Presentations
Sunday September 17, 2017 1:30pm - 2:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

2:45pm

The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients

The high frequency of anxiety disorders in patients with depression makes their recognition and treatment clinically important. Evidence suggests that anxiety disorders are underdiagnosed in patients with depression, despite being associated with increased psychosocial morbidity and possibly with differential treatment response. It is important for clinicians to be aware of which treatment approaches have been found to be as effective for depressed patients with and without comorbid anxiety, and which treatments have been found to be more effective than others. It is also important for clinicians to become familiar with the DSM-5 anxious distress specifier, as this may be a simpler approach toward assessing anxiety in patients with depression than the assessment of comorbid anxiety disorders.


Speakers
avatar for Mark Zimmerman, MD

Mark Zimmerman, MD

Professor of Psychiatry and Human Behavior, Brown Medical School; Director of Outpatient Psychiatry and Partial Hospital Program, Rhode Island Hospital | | Mark Zimmerman, MD, is a Professor of Psychiatry and Human Behavior at Brown University and Director of the Partial Hospital Program and Outpatient Division at Rhode Island Hospital in Providence, Rhode Island. Dr. Zimmerman received his undergraduate degree from Columbia University, and his medical degree from Chicago Medical School. He completed his postgraduate training at the Medical College of Pennsylvania, and held an academic appointment as assistant professor at the same time he was a resident in psychiatry. | Dr. Zimmerman is the principal investigator of the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project. The goal of the MIDAS project has been to integrate research methodology into routine clinical practice in order to improve clinical practice. The MIDAS project is the largest clinical epidemiological study using standardized measures that has been conducted in clinical... Read More →


Sunday September 17, 2017 2:45pm - 4:00pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

2:45pm

Is Psychiatry Safe? De-escalating Agitated and Violent Patients

Violence in the workplace has reached epidemic levels nationally in psychiatry, with studies showing over 50% of mental health professionals having endured both verbal and physical assaults in their career. This session will address the issue of physiological state dysregulation regardless of psychiatric etymology, and how to best interpret and control the relational milieu using proven neurophysiological cuing techniques based on the Polyvagal Theory. Mental health professionals will be able to monitor and downregulate their own stress response to not endure the persistent physical and psychological sequelae that become secondary posttraumatic stress disorder.


Speakers
avatar for Eric Arauz, MLER

Eric Arauz, MLER

Psych Congress Steering Committee Member; President, Trauma Institute of New Jersey, LLC; Adjunct Faculty Instructor, Rutgers University Robert Wood Johnson Medical School, Piscataway, New Jersey | Considered one of the best pure orators in the United States, Eric Arauz is the lead trainer and international keynote speaker through his consulting firm, A.I.E., specializing in living with trauma/PTSD, suicide-related issues, child abuse, veterans issues, and addiction. Having suffered extensive child abuse at the hands of a father with mental illness, and his own institutionalization in 1995, Mr. Arauz speaks openly about his personal... Read More →


Sunday September 17, 2017 2:45pm - 4:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

2:45pm

Optimizing Treatment in Schizophrenia: An Update

Despite decades of pharmacologic advances, schizophrenia remains one of the most serious mental disorders, with high relapse and low recovery rates. This session will: 1) Identify the challenges that patients with schizophrenia face at different stages of their illness and to help clinicians select matching treatment options; 2) Determine ways to increase patient engagement and delivery of multimodal, integrated care aiming to balance efficacy and safety of pharmacologic treatments; and 3) Individualize the available maintenance treatment options for patients with schizophrenia, weighing their respective pros and cons using sensible shared decision-making approaches.


Speakers
avatar for Christoph Correll, MD

Christoph Correll, MD

Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York | | Christoph Correll, MD, is currently Professor of Psychiatry at Hofstra Northwell School of Medicine, New York, and Medical Director of the Recognition and Prevention program at the Zucker Hillside Hospital, New York. Dr. Correll completed his medical studies at both the Free University of Berlin in Germany, and at the Dundee University Medical School in Scotland. Dr. Correll is board-certified in both general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York City. Dr... Read More →


Sunday September 17, 2017 2:45pm - 4:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

4:15pm

My Path Through Life with Autism

This session will provide insights into how people with autism think and feel. Problems with obtaining employment is a major issue for many individuals with autism. Dr. Grandin will extensively discuss how to be successful in the workplace. 


Speakers
avatar for Temple Grandin, PhD

Temple Grandin, PhD

Author, Speaker, Advocate; Professor, Animal Science, Colorado State University, Fort Collins, Colorado | | Born on August 29, 1947, in Boston, Massachusetts, Temple Grandin was diagnosed with autism as a child and went on to pursue work in psychology and animal science. She has become a leading advocate for autistic communities and has also written books and provided consultation on the humane treatment of animals. In 2010, HBO released an Emmy Award winning film on... Read More →


Sunday September 17, 2017 4:15pm - 5:15pm
La Nouvelle Orleans A - C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

5:30pm

Exhibit Hall Reception and Poster Gala
Sunday September 17, 2017 5:30pm - 7:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

5:45pm

Psych Congress Network Live!
Sunday September 17, 2017 5:45pm - 7:15pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130
 
Monday, September 18
 

7:00am

Industry-Supported Symposia: New Advances in the Management of Tardive Dyskinesia
Breakfast will be served. Seating for these sessions is available on a first-come,first-served basis. Admittance is based on availability and is not guaranteed. Pleaseplan to arrive early to ensure a seat. Breakfast will only be available until 8 A.M.

Even though it is common, tardive dyskinesia (TD) is a neglected side effect ofthe atypical antipsychotics. This symposium will address the prevalence, diagnosisincluding AIMS examination, and evidence-based treatments for TD.

Supported by an educational grant from Neurocrine Biosciences.



Monday September 18, 2017 7:00am - 9:00am
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

7:00am

Industry-Supported Symposia: New Developments in Bipolar Spectrum Disorders in Children and Adolescents
Breakfast will be served. Seating for these sessions is available on a first-come, first-served basis.  Admittance is based on availability and is not guaranteed. Please plan to arrive early to ensure a seat. Breakfast will only be available until 8 A.M.

In this symposium, expert faculty will present case-based updates on the diagnosis and management of bipolar spectrum disorders in children and adolescents. The discussion will include practical approaches to diagnostic challenges, management of medical and psychiatric comorbidities, and evidence-based pharmacologic strategies.

Supported by an educational grant from Sunovion Pharmaceuticals Inc.


Monday September 18, 2017 7:00am - 9:00am
La Nouvelle Orleans C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Solving Clinical Challenges in Substance Use Disorders

“Solving Clinical Challenges” addresses complex conundrums that are faced by Psych Congress attendees in managing their patients with substance use disorders. Dr. Kosten will discuss and respond to real cases and real issues from attendees who were surveyed prior to the conference. Challenges that may be covered include: 1) diagnostic nosology, accurate diagnosis, and screening; 2) pharmacologic treatments; 3) side effect management; 4) non-pharmacologic treatments.


Speakers
avatar for Thomas Kosten, MD

Thomas Kosten, MD

Waggoner Chair and Professor of Psychiatry and Neuroscience, Baylor College of Medicine & MD Anderson Cancer Center, Houston, Texas | | Thomas R. Kosten, MD, is the JH Waggoner Chair and Professor of Psychiatry, Pharmacology, and Neuroscience, Vice-Chair for Psychiatry, and Co-Director of the Dan L. Duncan Institute for Clinical and Translational Research at Baylor College of Medicine. His other key appointments are Distinguished Professor of Psychiatry at Peking University Medical School and Professor of Epidemiology and of Behavioral Health at MD Anderson Cancer Prevention Center. Dr, Kosten is a former Professor at Yale University School of Medicine, the founding Vice-Chair for Addiction Psychiatry of the American Board of Psychiatry and Neurology, as well as Past President of both the American Academy of Addiction Psychiatry and the College on Problems of Drug Dependence. He is a Distinguished Life Fellow in the American Psychiatric Association and a Fellow of the American College of Neuropsychopharmacology. Dr. Kosten has served as a Congressional Fellow in the United States House of Representatives and has been a long-standing member of various substance abuse commissions for the National Academy of Sciences, as well as various advisory boards for the Food and Drug Administration and the Department of Defense, primarily related to veteran health, drug safety, and risk management. Since 2001, based on an annual ranking by U.S. News... Read More →


Monday September 18, 2017 9:15am - 10:30am
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Update on Treatment-Resistant Major Depressive Disorder

This session will provide mental health professionals with an update on treatment-resistant major depressive disorder. Dr. Papakostas will review the evidence in favor of or against various therapies. In addition, ongoing cutting-edge research in this area will be presented.


Speakers
avatar for George Papakostas, MD

George Papakostas, MD

Scientific Director, Massachusetts General Hospital Clinical Trials Network Institute | | George I. Papakostas, MD is Scientific Director of the Massachusetts General Hospital Clinical Trials Network and Institute, and Associate Professor of Psychiatry at Harvard Medical School in Boston, Massachusetts... Read More →


Monday September 18, 2017 9:15am - 10:30am
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Pharmacological Augmentation of Evidence-Based Treatment for PTSD: Emerging Methods Toward the Individualization of Treatment Protocols

This session will summarize recent efforts to enhance cognitive behavioral therapies (CBT) with pharmacological agents as a backdrop to a more specific discussion related to increasing noradrenergic activity (with yohimbine, an alpha-2 adrenergic receptor antagonist), or decreasing it (with prazosin, an alpha-1 adrenergic antagonist) during prolonged exposure therapy for posttraumatic stress disorder. The overarching aim is to use these 2 contrasting examples, in context with the literature, to highlight how current augmentation studies have applied specified research designs, methods, and objective measurement paradigms that have actionable impact for practitioners and researchers beyond study-specific findings. These studies are laying the long-awaited methodological foundations for individualizing treatments by discovering for whom, when, and under what circumstances evidence-based treatments will be effective. Mental health professionals should be able to synthesize evidence-informed pros and cons related to treatment choices for their patients. Moreover, although the rapidly expanding literature base related to CBT treatment augmentation with pharmacotherapy can be specialized, especially in translational extinction learning contexts, the methods and outcomes of many of these studies are relevant to a general audience of practitioners and to their patients.


Speakers
avatar for Mark Hamner, MD

Mark Hamner, MD

Professor, Medical University of South Carolina; Medical Director, PTSD Clinic, VA Medical Center, Charleston, South Carolina | | Mark B. Hamner, MD, is a Professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. Dr. Hamner is also the Medical Director of the Posttraumatic Stress Disorder Clinical Team (PCT) at the Ralph H. Johnson Department of Veterans Affairs Medical Center in Charleston. Dr. Hamner received his medical degree from the University of North Carolina School of Medicine in Chapel Hill, where he also completed his internship and residency in the Department of Psychiatry. Dr. Hamner is board-certified in Psychiatry with added qualifications in Geriatric Psychiatry. He is a member of many professional organizations, including the American Psychiatric Association (fellow status), American Association of Geriatric Psychiatry, and others. Dr. Hamner is also an active member on many boards and committees, and has served in numerous administrative leadership roles. Dr. Hamner has a keen interest in the ethics of clinical care and research as reflected by his longstanding service on Institutional Review Boards including his current role as Chair of IRB1 at MUSC. His clinical and research interests include treatment of posttraumatic stress disorder (PTSD), mood disorders, schizophrenia, neurobiology of PTSD, phenomenology of co-morbidities in PTSD, and neuroendocrinology. Dr. Hamner has lectured extensively on various topics in clinical psychiatry and has authored more than 200 peer-reviewed journal articles, research abstracts, and book or encyclopedia chapters. In addition, he has been the recipient of approximately 80 clinical trial or basic clinical science... Read More →
avatar for Peter Tuerk, PhD

Peter Tuerk, PhD

Associate Professor of Psychiatry and Behavioral  Sciences, Medical University of South Carolina; Director, PTSD Clinical and Telehealth Team, Charleston, VA Medical Center | | Peter Tuerk, PhD, is a clinical psychologist who specializes in evidence-based treatments for Post-Traumatic Stress Disorder (PTSD), associated research and training, and the integration of technology into clinical care. Dr. Tuerk earned his doctorate at the University of Virginia and is an Associate Professor of Psychiatry and Behavioral Sciences at the Medical University of South Carolina. He serves as Section Chief of the PTSD Clinical and Telehealth Teams at the Charleston Veterans Affairs Medical Center, a nationally recognized program for expanding access to evidence-based PTSD care via clinical training, telehealth service development, and proactive ongoing program evaluation. Dr. Tuerk has served as a Primary Investigator on Veterans Affairs, the U.S. Department of Defense (DoD), and the National Institutes of Health research awards, focusing on improving evidence-based behavioral care in standard treatment settings. He has authored numerous peer-reviewed publications, chapters, and government reports related to mental health care delivery. He chaired the VA National Strategy Taskforce for PTSD Telehealth and is editor of... Read More →


Monday September 18, 2017 9:15am - 10:30am
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Addressing Pharmacologic Issues in Insomnia

Insomnia is a common problem that is highly prevalent among people with mental health disorders. The treatment of insomnia often is challenging due to the multiple influences that can undermine sleep quality and quantity. Dr. Neubauer will briefly review the problem of insomnia and provide an overview of therapeutic approaches. The primary focus of this session will be targeted pharmacologic approaches that address specific patient populations and symptoms complexes. The consideration of medications for insomnia should include both pharmacokinetic and pharmacodynamic properties. In this way, pharmacotherapy can be customized for individual patients.


Speakers
avatar for David Neubauer, MD

David Neubauer, MD

Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland | | David Neubauer, MD, is an Associate Professor of Psychiatry at the Johns Hopkins University School of Medicine and Associate Director of the Johns Hopkins Sleep Disorders Center. Dr. Neubauer is a Fellow of the American Academy of Sleep Medicine and the American Psychiatric Association. He is a member of the Sleep Research Society. Dr. Neubauer was educated at the University of Miami School of Medicine and received his residency training at Johns Hopkins Hospital. He has a clinical interest in the relationships among sleep, circadian rhythms, and psychiatric disorders. He is author... Read More →


Monday September 18, 2017 9:15am - 10:30am
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

More Attention. Less Stimulants.

Best practices in attention-deficit/hyperactivity disorder (ADHD) management require skilled use of alternative treatments in conjunction with evidence-based medication use. This session will review the practical use of cognitive-behavioral therapy, mindfulness/meditation, and exercise therapies. Dr. Mason will also discuss primary use of non-stimulant medication with stimulant augmentation in partial responders, which can be an effective and tolerable alternative to stimulant monotherapy.


Speakers
avatar for Oren Mason, MD

Oren Mason, MD

Associate Professor in the Department of Family Practice, Michigan State University College of Human Medicine; Clinical Associate Instructor, Wayne State University School of Medicine’s Grand Rapids Medical Education Consortium, Detroit, Michigan | | Oren W. Mason, MD, is a family physician since 1988, and an Assistant Professor at Michigan State University College of Human Medicine... Read More →


Monday September 18, 2017 10:45am - 12:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Summary of the ABPN MOC Program: Life-Long Learning for Psychiatrists and Neurologists

Have you completed your American Board of Psychiatry and Neurology, Inc. (ABPN) Maintenance of Certification (MOC) requirements? All psychiatrists certified by the ABPN after 1994 are required to take part in the MOC program, yet many remain unclear as to where to begin the process. This session, led by an MOC Ambassador, will provide an easy-to-follow roadmap to MOC, outlining the rationale and background of MOC, as well as the 4-part ABPN MOC program components.


Speakers
avatar for Josepha A. Cheong, MD

Josepha A. Cheong, MD

Professor, University of Florida College of Medicine, Department of Psychiatry; Assistant Chief, Psychiatry, Nashville VAMC | | Josepha A. Cheong, MD is the Assistant Chief of Psychiatry for the Tennessee Valley Healthcare System (Nashville and Murfreesboro VA Medical Centers) and Professor of Psychiatry and Neurology at the University Of Florida College Of Medicine. Dr. Cheong primary areas of clinical focus are medical education, geriatric, emergency, and consult-liaison psychiatry. She is a member of the ACGME Psychiatry RRC and its Executive Subcommittee. In January 2017, Dr. Cheong began her term as a Director on the American Board of Psychiatry and Neurology. Primary areas of education focus are program development, post-graduate education, ethics, and social media. Memory and affective disorders, neuropsychopharmacology, and management of agitation and aggression are within her clinical expertise. Dr. Cheong is highly regarded as a teacher and has received numerous awards at regional, state and national levels as well as a sought-after educational speaker and... Read More →


Monday September 18, 2017 10:45am - 12:00pm
Room 245 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Examining the Risks and Benefits from Benzodiazepines

Benzodiazepines are some of the America’s most widely used medications, and they undeniably have helped a large number of patients. However, recent data shows that they harm a previously unknown, large number of patients. Risks include physical dependence, addiction, withdrawal seizures, memory problems, dementia risk elevation, and falls. A new black box warning regarding co-administration of these drugs is now part of the U.S. Food and Drug Administration directive to us clinicians. Despite clear reasons for concern, these drugs are also necessary and effective in multiple acute and chronic settings. The goal of this session is to offer state-of-the-art information on the risk–benefit profile of these medications and offer clear, practical advice to clinicians in order to minimize harm and maximize benefits.


Speakers
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Psych Congress Steering Committee Member; Private Practice, Austin, Texas; Adjunct Clinical Affiliate, School of Nursing, University of Texas at Austin, Austin, Texas | | Saundra Jain, MA, PsyD, LPC, provides workshops to healthcare practitioners, organizations, businesses, and individuals interested in learning more about the power of wellness. In 1992, Dr. Jain launched a private practice of psychotherapy, where she currently provides services for a wide range of mental health issues. | | Dr. Jain is very active in the area of peer-to-peer education, especially in the disease states of depression, bipolar disorder, anxiety disorders, and ADHD. Another strong clinical and educational interest involves differential diagnosis of major psychiatric disorders. She is the co-creator and co-presenter of a novel and extremely well-received interactive workshop/program addressing the challenges of dealing with psychiatric comorbidities through the use of psychiatric scales and screeners. This program reached a national audience, and according to many attendees changed the way they practice medicine. Dr. Jain has been instrumental in developing several other innovative tools/programs to fill current gaps in this area. She is the co-creator and co-presenter featured on an interactive DVD titled Differentiating Bipolar Depression from Unipolar Depression. Recently, Dr. Jain served as the co-host... Read More →
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Psych Congress Co-Chair; Clinical Professor, Department of Psychiatry,Texas Tech Health Sciences Center, School of Medicine, Midland, Texas | | Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India and attended graduate school at the University of... Read More →


Monday September 18, 2017 10:45am - 12:00pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Biological Rhythms and Wellness: The Roles of Sleeping and Eating

We strive for wellness through a healthy diet, exercise, and prioritizing time for adequate sleep. Recent evidence confirms the important role of sleep for optimum cognitive, metabolic, endocrine, and immune functioning. Emerging data now shows that the timing of our sleep-wake patterns, as well as what we eat and when we eat it, further influences our biological rhythms and impacts our health. This session will provide an update of recent scientific literature focused on sleep, diet, and biological rhythms, and then review translational approaches that highlight modifiable behaviors that can help us enhance our health.


Speakers
avatar for David Neubauer, MD

David Neubauer, MD

Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland | | David Neubauer, MD, is an Associate Professor of Psychiatry at the Johns Hopkins University School of Medicine and Associate Director of the Johns Hopkins Sleep Disorders Center. Dr. Neubauer is a Fellow of the American Academy of Sleep Medicine and the American Psychiatric Association. He is a member of the Sleep Research Society. Dr. Neubauer was educated at the University of Miami School of Medicine and received his residency training at Johns Hopkins Hospital. He has a clinical interest in the relationships among sleep, circadian rhythms, and psychiatric disorders. He is author... Read More →


Monday September 18, 2017 10:45am - 12:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theaters (Non-CME): A Long-Term Treatment Plan for Patients with Schizophrenia
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Janssen Pharmaceuticals, Inc.

Monday September 18, 2017 12:15pm - 1:30pm
Room 353 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theaters (Non-CME): Learn More About an Adjunctive Treatment for Adults with Major Depressive Disorder
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC.

Monday September 18, 2017 12:15pm - 1:30pm
Room 252 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theaters (Non-CME): Treatment Advances in Parkinson’s Disease Psychosis: Transforming the Standard of Care for Hallucinations and Delusions
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by ACADIA Pharmaceuticals Inc.

Monday September 18, 2017 12:15pm - 1:30pm
Room 356 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theaters (Non-CME): Update in the Management of Tardive Dyskinesia
Non-CME. Lunch will be served. Seating is limited to 200 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Teva Neuroscience, Inc.

Monday September 18, 2017 12:15pm - 1:30pm
Room 255 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Exhibit Hall and Poster Pavilion
Monday September 18, 2017 12:15pm - 2:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

12:30pm

Product Showcases in the Exhibit Hall
Monday September 18, 2017 12:30pm - 1:00pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

1:30pm

Psych Congress Network Live!
Monday September 18, 2017 1:30pm - 2:00pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

1:30pm

Poster Presentations
Monday September 18, 2017 1:30pm - 2:30pm
New Orleans Ernest N. Morial Convention Center 900 Convention Center Blvd. New Orleans, LA 70130

2:45pm

Treating Children and Adolescents with Mood Disorders

This session will review the evidence base for the safety and efficacy of pharmacologic treatments for children and adolescents with mood disorders to enhance mental health professionals’ knowledge regarding treatment decisions.


Speakers
avatar for Adelaide Robb, MD

Adelaide Robb, MD

Professor of Psychiatry and Pediatrics, The George Washington University; Division Chief, Psychology and Behavioral Health, Children's National Health System, Washington DC | | Adelaide Robb, MD, is a professor of Child and Adolescent Psychiatry at George Washington University and... Read More →


Monday September 18, 2017 2:45pm - 4:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

2:45pm

The NYU Psilocybin Cancer Project

Psychedelic-assisted psychotherapy is a new area of clinical research unknown to most clinicians. This session will report on the history of psychedelic-assisted psychotherapy for cancer-related psychological and existential distress. Dr. Ross will discuss findings of a recently published randomized controlled trial of psilocybin-assisted psychotherapy for cancer-related psychological and existential distress. 


Speakers
avatar for Stephen Ross, MD

Stephen Ross, MD

Associate Professor, Department of Psychiatry, New York University of Medicine; Senior Director, Division of Alcoholism and Drug Abuse, Department of Psychiatry, Bellevue Hospital | | Stephen Ross, M.D. is Associate Professor of Psychiatry and Child & Adolescent Psychiatry at the New York University (NYU) School of Medicine and Associate Professor of Oral and Maxillofacial Pathology, Radiology and Medicine at the NYU College of Dentistry. Dr. Ross is the Director of the Division of Alcoholism and Drug Abuse in the Psychiatry Department at Bellevue Hospital Center, Director of Addiction Psychiatry at NYU Langone Medical Center/Tisch Hospital, and the Director of the NYU Addiction Fellowship. | | Dr. Ross directs a National Institute of Health funded Addictive Disorders Laboratory at Bellevue Hospital Center and is the Director of the NYU Psychedelic Research Group. Dr. Ross researches the therapeutic application of hallucinogen treatment models to treat psychiatric and addictive disorders. He is an expert in psycho-oncology and is studying novel pharmacologic-psychosocial approaches to treating psychological distress associated with advanced or terminal cancer. Dr. Ross is the Principal Investigator (PI) of the NYU Psilocybin Cancer Project (a recently completed FDA phase II RCT studying the efficacy of psilocybin-assisted psychotherapy in patients with life-threatening cancer and psychological/existential distress), PI of a controlled trial administering psilocybin to religious professionals, and co-PI of a controlled trial assessing psilocybin-assisted psychotherapy in patients with alcoholism. Dr. Ross receives his research funding from the National Institute on Drug Abuse, the NYU School of Medicine and the Heffter Research Institute... Read More →


Monday September 18, 2017 2:45pm - 4:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

2:45pm

Weight Gain and Metabolic Abnormalities in Patients with Schizophrenia

New information is available regarding more recently approved antipsychotics, as well as studies examining the risk of metabolic abnormalities in patients with schizophrenia. This session will focus on factors related to metabolic health in patients with schizophrenia. New findings regarding the propensity of second-generation antipsychotics to be associated with weight gain and metabolic abnormalities, as well as interventions designed to reduce weight gain and/or metabolic abnormalities, will be discussed.


Speakers
avatar for Leslie Citrome, MD, MPH

Leslie Citrome, MD, MPH

Clinical Professor of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York | | Leslie Citrome, MD, MPH, is a Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York, and has a private practice in Pomona, New York. Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. He graduated from the McGill University Faculty of Medicine and completed a residency and chief residency in Psychiatry at the New York University School of Medicine, and went on to complete a Master in Public Health at Columbia University. He is Editor in Chief of... Read More →


Monday September 18, 2017 2:45pm - 4:00pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

4:15pm

DSM-5 Schizophrenia Spectrum and Other Psychotic Disorders: Knowing It Better and Improving Clinical Practice

Although DSM-5 has been utilized for over three years, most mental health professionals remain unaware of some key high-level changes and are therefore unable to apply some of its most useful tools to their clinical practice. This session will review these changes (diagnosis as a three-step process; new tools to more precisely implement this process) and their clinical implications, and application to treatment will be discussed with the use of clinical vignettes.


Speakers
avatar for Rajiv Tandon, MD

Rajiv Tandon, MD

Professor of Psychiatry, Department of Psychiatry, University of Florida, Gainesville, Florida Rajiv Tandon, MD, is Professor of Psychiatry at the University of Florida College of Medicine in Gainesville, Florida. Dr. Tandon has authored more than 300 scientific publications and given over 1,000 national and international scientific presentations. He has received several awards for research and teaching in schizophrenia, including the 2010 and 2016 SIRS (International Schizophrenia Research Society) Senior Researcher of the Year awards for the most-cited paper in schizophrenia between 2008-2010 and the most downloaded paper in schizophrenia between 2014-2016. Dr. Tandon has received the Exemplary Psychiatrist Award from the National Alliance for Mental Illness on three occasions: in 2009, 2012, and 2015. He was a member of... Read More →


Monday September 18, 2017 4:15pm - 5:30pm
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

4:15pm

Psychiatry Meets the Microbial World

No scientific discovery in the last decade has been more shocking than the realization of just how thoroughly physical health depends upon the trillions of microbes that call our bodies home. While this discovery has been increasingly integrated into how we understand and treat a range of immune-related physical conditions, it is only now that the full impact of these human-microbial interactions for mental health are being understood. Dr. Raison will provide a cutting-edge view of the biology of microbial-human interactions relevant for a range of psychiatric conditions, including depression and autism, with a focus on evidence that the current epidemic of immune-related mental disorders has arisen in large measure as a result of disruptions in ancient co-evolved relationships with the microbial world. This session will conclude by reviewing evidence suggesting that microbial products may hold promise for the treatment of a range of psychiatric conditions.


Speakers
avatar for Charles Raison, MD

Charles Raison, MD

Psych Congress Co-Chair; Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin | | Charles L. Raison, MD, is the Mike and Mary Sue Shannon Endowed Chair in Mind, Body, and Family Well-being, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, Wisconsin. Prior to this he was Professor in the Department of Psychiatry, College of Medicine, and the Barry and Janet Lang Professor of Integrative Mental Health at the Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona. | Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. In 2014 Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association... Read More →


Monday September 18, 2017 4:15pm - 5:30pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

4:15pm

Boundary Issues in Clinical Practice

The topic of treatment boundaries often presents some subtle dilemmas for clinical assessment. Yet many clinicians struggle with boundary questions and issues. These dilemmas, questions, and uncertainties are far from merely academic; a number of civil suits, ethics complaints, and—more seriously—boards of registration cases, which threaten a clinician’s livelihood, show that this is an area in which clarity is essential. This session will address these matters in depth.


Speakers
avatar for Thomas Gutheil, MD

Thomas Gutheil, MD

Professor of Psychiatry, Beth Israel-Deaconess Medical Center, Massachusetts Mental Health Center, Harvard Medical School | | Thomas G. Gutheil, MD, is a Professor of Psychiatry and Co-Founder of the Program in Psychiatry and the Law at Harvard Medical School, Boston, Massachusetts. Dr. Gutheil is the recipient of every major award in the forensic field, as well as multiple teaching and writing awards. He is the former president of the American Academy of Psychiatry and Law and the current president of the International Academy of Law and Mental Health. Dr. Gutheil has been an author or co-author of over 250 publications, some of which have been translated into other languages, and many of which are used in almost every forensic training program in the country. An internationally known authority, speaker, and consultant on medicolegal issues, malpractice, liability prevention, and risk management, Dr. Gutheil has served as a consulting expert or expert witness in 42 states. Dr. Gutheil lives and works in the Boston... Read More →


Monday September 18, 2017 4:15pm - 5:30pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

5:45pm

Reexamining “Depression” and Antidepressants: A New Approach

This session will examine the research literature on the diagnostic validity of the “major depressive disorder” concept, and the alternative diagnoses of “manic-depressive illness” and “neurotic depression.” The treatment of the types of depressive states, specifically melancholia, mixed depression, vascular, and neurotic depression, will be examined. The limitations of antidepressants in specific subtypes will be reviewed, as well as data on the benefits of neuroleptics (dopamine blockers) and mood stabilizers. This session will provide attendees with a means of applying that knowledge in clinical practice. Clinical applications will be emphasized.


Speakers
avatar for Nassir Ghaemi, MD, MPH

Nassir Ghaemi, MD, MPH

Professor of Psychiatry, and Director, Mood Disorders Program, Tufts Medical Center | | S. Nassir Ghaemi, MD, MPH, is a psychiatrist and researcher with expertise in depression and bipolar illness, and training in philosophy and public health. Dr. Ghaemi has published over 200 scientific articles or book chapters and over half a dozen books, and is Associate Editor... Read More →


Monday September 18, 2017 5:45pm - 6:45pm
La Nouvelle Orleans A - C The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

7:00pm

Innovation Theater (Non-CME): A Novel Delivery System for Stimulant Medications for the Treatment of ADHD
Non-CME. Dinner will be served. Seating is limited to 175 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Dinnerwill only be available until 7:30 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Neos Therapeutics, Inc.

Monday September 18, 2017 7:00pm - 8:15pm
Room 252 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130
 
Tuesday, September 19
 

7:00am

Industry-Supported Symposia: Nonadherence in Schizophrenia: Investigating the Clinical Utility of Long-Acting Injectable Antipsychotics on Treatment Adherence
Breakfast will be served. Seating for this session is available on a first-come, firstservedbasis. Admittance is based on availability and is not guaranteed. Please planto arrive early to ensure a seat. Breakfast will only be available until 8 A.M.

Nonadherence rates among persons with schizophrenia are estimated at 50%.Nonadherence to antipsychotic treatment is a primary reason for relapse and isassociated with increased hospitalization, higher risk of suicide, longer time toremission, poor prognosis, psychiatric emergencies, incarceration, and greaterhealthcare utilization. In this session, Drs. Kane and McEvoy will lead theaudience through a case-based analysis to identify challenges to adherence,outline pharmacotherapy interventions, and review shared decision makingprinciples designed to overcome prescription nonadherence and increasepatient outcomes.

Supported by an educational grant from Alkermes, Inc.

Tuesday September 19, 2017 7:00am - 9:00am
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Delivering and Measuring the Outcomes of Cognitive Remediation Across Clinical Settings

Cognitive remediation therapy (CRT) is widely disseminated and has become commonplace. Meta-analyses of the efficacy of CRT have generally concluded that CRT offers statistically significant, but small, effects in several different conditions including schizophrenia, major depression, traumatic brain injury and stroke, and mild cognitive impairment. However, these reviews have also suggested that CRT improves cognitive performance, but not functional skills. Combining skills training programs and functional skills training leads to systematic functional gains, particularly in terms of employment as an outcome. Topics that will be communicated and discussed in this session include: Who benefits from CRT (age and diagnosis, early course vs. chronic)? How is CRT best delivered (in person/over the internet)? What additional skills training should be offered? How are outcomes measured? Are there different strategies required for public sector and private rehabilitation services?


Speakers
avatar for Raymond Kotwicki, MD, MPH

Raymond Kotwicki, MD, MPH

Chief Medical Officer, Skyland Trail | | Raymond Kotwicki, MD, MPH, is Chief Medical Officer at Skyland Trail, a nationally acclaimed private, non-profit residential and day treatment facility for adults with mental illnesses in Atlanta, Georgia. In this role, Dr. Kotwicki oversees all the clinical, educational, and research activities within the organization. Dr. Kotwicki trained as a Department of Energy Fellow, and was a Medical Scholar at the University of Wisconsin Medical School. He had post-graduate training at Harvard Medical School, the Boston University School of Medicine, and Emory University, where he earned a Master in Public Health degree in Health Policy and Management. Dr. Kotwicki remains on the adjunctive faculty at both the Emory University School of Medicine as well as the University of Miami Miller School of Medicine. Dr. Kotwicki is a Diplomate of the American Board of Psychiatry and Neurology, and is President of the Georgia Psychiatric... Read More →
avatar for Alice Medalia, PhD

Alice Medalia, PhD

Clinical Director, Cognitive Health Services, New York State Office of Mental Health; Professor of Medical Psychology, Columbia University Medical Center, Columbia University College of Physicians and Surgeons | | Alice Medalia, PhD is a Professor and Director of Psychiatric Rehabilitation Services in the Department of Psychiatry at Columbia University Medical Center and Clinical Director of Cognitive Health Services for the New York State Office of Mental Health... Read More →
avatar for Richard Keefe, PhD

Richard Keefe, PhD

Professor in Psychiatry and Behavioral Sciences; Professor, Department of Psychology & Neuroscience, Duke University School of Medicine | | Richard Keefe, Ph.D., is Professor of Psychiatry, Psychology, and Neurosciences at Duke University Medical Center in Durham, North Carolina. Dr. Keefe received his BA from Princeton University and his Ph.D. in clinical psychology from New York University... Read More →
avatar for Philip D. Harvey, PhD

Philip D. Harvey, PhD

Leonard M. Miller Professor of Psychiatry and Behavioral Sciences,University of Miami Miller School of Medicine | | Philip D. Harvey, PhD is Leonard M. Miller Professor of Psychiatry and director of the Division of Psychology at the University of Miami Miller School of Medicine and a VA Senior Health Scientist. Dr. Harvey was formerly professor of Psychiatry at Emory University School of Medicine and Mt. Sinai School of Medicine... Read More →


Tuesday September 19, 2017 9:15am - 10:30am
Hall E-3 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

The Promise and Perils of Ketamine in Psychiatric Practice

Ketamine is a U.S. Food and Drug Administration-approved anesthetic agent, which is increasingly being used “off label” for various psychiatric conditions. This session will educate practicing clinicians about the use of ketamine for psychiatric disorders, especially its use in treatment-resistant mood disorders and posttraumatic stress disorder. An overview of data from controlled research studies and experience in clinical practice settings will be presented. Important unresolved issues will be examined, including patient selection, treatment implementation (dose optimization, route of administration, maintenance treatment), and risk management, with the goal of providing a balanced view of a controversial “off-label” therapy.


Speakers
avatar for Sanjay J. Mathew, MD

Sanjay J. Mathew, MD

Johnson Family Chair for Research in Psychiatry; Professor of Psychiatry & Behavioral Sciences, Baylor College of Medicine; Staff Clinician, Michael E. Debakey VA Medical Center, Houston, Texas | Sanjay J. Mathew, MD, is the Johnson Family Chair for Research in Psychiatry and an Associate Professor with tenure in the Menninger Department of Psychiatry and Behavioral Sciences. Dr. Mathew is also a staff psychiatrist at the Michael E. Debakey Veterans Affairs Medical Center in Houston, Texas. His research program is the recipient of federal grants and contracts from the National Institute of Mental Health and the Department of Veterans Affairs to develop novel therapies for patients with treatment-resistant depression and Post-traumatic Stress Disorder. Dr. Mathew's translational research program focuses on testing of experimental therapies for depression and anxiety, and discovering illness and treatment-related biomarkers. Much of his work has focused on glutamate modulating agents, which act as rapidly acting antidepressants. Dr. Mathew graduated from Dartmouth College with a degree in Biology, and received his medical degree from Baylor College of Medicine. Dr. Mathew completed his residency training in Psychiatry at Columbia University's College of Physicians and Surgeons and the New York State Psychiatric Institute, where he also completed a National Institute of Mental Health research fellowship. Dr. Mathew began his faculty career at the Mount Sinai School of Medicine in New York, where he directed the Mood and Anxiety Disorders Program. Dr. Mathew has directed the Baylor program since... Read More →


Tuesday September 19, 2017 9:15am - 10:30am
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

9:15am

Creating a Mental Wellness Practice Incorporating HERO Principles (Happiness, Enthusiasm, Resilience and Optimism)

In mental health, we’re trained to focus on reduction of symptoms, achieving remission, and improving outcomes; and as a result, may overlook the power of wellness as a treatment strategy. The goal of this session is to highlight the importance of wellness in everyday clinical practice. Dr. Jain will review different elements of wellness and the neurobiological changes seen as a result of wellness behaviors and activities. Four mental wellness traits—happiness, enthusiasm, resilience, and optimism—will also be discussed, along with practical tips on how these traits can be enhanced through wellness interventions in our practices.


Speakers
avatar for Saundra Jain, MA, PsyD, LPC

Saundra Jain, MA, PsyD, LPC

Psych Congress Steering Committee Member; Private Practice, Austin, Texas; Adjunct Clinical Affiliate, School of Nursing, University of Texas at Austin, Austin, Texas | | Saundra Jain, MA, PsyD, LPC, provides workshops to healthcare practitioners, organizations, businesses, and individuals interested in learning more about the power of wellness. In 1992, Dr. Jain launched a private practice of psychotherapy, where she currently provides services for a wide range of mental health issues. | | Dr. Jain is very active in the area of peer-to-peer education, especially in the disease states of depression, bipolar disorder, anxiety disorders, and ADHD. Another strong clinical and educational interest involves differential diagnosis of major psychiatric disorders. She is the co-creator and co-presenter of a novel and extremely well-received interactive workshop/program addressing the challenges of dealing with psychiatric comorbidities through the use of psychiatric scales and screeners. This program reached a national audience, and according to many attendees changed the way they practice medicine. Dr. Jain has been instrumental in developing several other innovative tools/programs to fill current gaps in this area. She is the co-creator and co-presenter featured on an interactive DVD titled Differentiating Bipolar Depression from Unipolar Depression. Recently, Dr. Jain served as the co-host... Read More →


Tuesday September 19, 2017 9:15am - 10:30am
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Successful Aging in Dementia: Pitfalls and Promises

Successful aging has been well-characterized for older individuals with normal age-associated problems, but does the concept even apply when someone has a progressive dementia? Similarly, most life cycle theories have a lot to say about aging individuals up to and until they suffer from more severe conditions such as dementia, but what happens afterward? Do they still even apply at that point? My answer is that it is possible to characterize an optimal life course for those with dementia, including healthy lifestyle factors such as physical and mental exercise, adequate sleep, and nutrition, as well as more transcendent strengths such as wisdom, resilience, and creativity. This understanding is critical to enabling mental health professionals to both humanize and help their patients with dementia.


Speakers
avatar for Marc Agronin, MD

Marc Agronin, MD

Vice President, Behavioral Health and Clinical Research, Miami Jewish Health; Affiliate Associate Professor of Psychiatry and Neurology, University of Miami Miller School of Medicine Marc E. Agronin, MD, is a board-certified Adult and Geriatric Psychiatrist and the author of the acclaimed... Read More →


Tuesday September 19, 2017 10:45am - 12:00pm
Hall E-1 The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

10:45am

Dopamine Receptor Pharmacology: What We Clinicians Need to Know

Dopamine and its receptors are intimately involved in the pathogenesis of nearly every psychiatric disorder. While we clinicians use multiple treatments that affect these receptors, lack of deep knowledge of these receptors often leads to “blind” prescribing, resulting in suboptimal prescribing. To compound it further, many new psychotropics have vastly different and more precise effects on dopamine receptor family. There is urgent need for continuing medical education on the dopamine family of receptors and means by which we clinicians can target it precisely.


Speakers
avatar for Rakesh Jain, MD, MPH

Rakesh Jain, MD, MPH

Psych Congress Co-Chair; Clinical Professor, Department of Psychiatry,Texas Tech Health Sciences Center, School of Medicine, Midland, Texas | | Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India and attended graduate school at the University of... Read More →


Tuesday September 19, 2017 10:45am - 12:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

12:15pm

Innovation Theater (Non-CME): MDD: Looking Beyond Monoaminergic Pathways
Non-CME. Lunch will be served. Seating is limited to 600 attendees and will be available ona first-come, first-served basis. Please plan to arrive early to ensure a seat. Lunchwill only be available until 12:45 P.M.

Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives, and assess the value to your patient care.  

This presentation is provided by Alkermes, Inc.

Tuesday September 19, 2017 12:15pm - 1:30pm
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130

1:45pm

Out with the Old — In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications

The 60-year-old classification system of the approximately 150 medications utilized for the treatment of psychiatric disorders (antipsychotics, antidepressants, mood stabilizers, sedative-hypnotics, etc.) is being replaced by a neuroscience-based nomenclature. Most clinicians are unaware of this change or its implications. In this session, the rationale and nature of this change will be discussed and its clinical implications will be reviewed. Using clinical vignettes, the application of this system to the pharmacological treatment of different psychiatric disorders will be summarized. 


Speakers
avatar for Rajiv Tandon, MD

Rajiv Tandon, MD

Professor of Psychiatry, Department of Psychiatry, University of Florida, Gainesville, Florida Rajiv Tandon, MD, is Professor of Psychiatry at the University of Florida College of Medicine in Gainesville, Florida. Dr. Tandon has authored more than 300 scientific publications and given over 1,000 national and international scientific presentations. He has received several awards for research and teaching in schizophrenia, including the 2010 and 2016 SIRS (International Schizophrenia Research Society) Senior Researcher of the Year awards for the most-cited paper in schizophrenia between 2008-2010 and the most downloaded paper in schizophrenia between 2014-2016. Dr. Tandon has received the Exemplary Psychiatrist Award from the National Alliance for Mental Illness on three occasions: in 2009, 2012, and 2015. He was a member of... Read More →


Tuesday September 19, 2017 1:45pm - 3:00pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

3:00pm

Walk on the Wild Side or Walk on the Right Side? The Role of Psychedelics, Cannabinoids, and Opioids in Psychiatric Treatment

While illicit use of hallucinogens, cannabinoids, and opioids has been stigmatized in the past, emerging research demonstrates therapeutic benefits from selective use of psychedelics, cannabinoid derivatives, and kappa- and mu-opioid receptor modulators in controlled circumstances for the treatment of different psychiatric conditions, including mood disorders, anxiety disorders, posttraumatic stress disorder, and schizophrenia. The role of endocannabinoids and endogenous opioids in regulation of stress response and mood will be discussed, as well as relevant receptor pharmacology. Finally, available scientific research supporting their therapeutic use will be critically reviewed.


Speakers
avatar for Andrew Penn, RN, MS, NP, APRN-BC

Andrew Penn, RN, MS, NP, APRN-BC

Psych Congress Steering Committee Member; Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, California; Assistant Clinical Professor, School of Nursing, University of California, San Francisco, California | | Andrew Penn, RN, MS, NP, APRN-BC, was trained as an adu... Read More →
avatar for Charles Raison, MD

Charles Raison, MD

Psych Congress Co-Chair; Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology; Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin | | Charles L. Raison, MD, is the Mike and Mary Sue Shannon Endowed Chair in Mind, Body, and Family Well-being, Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, Wisconsin. Prior to this he was Professor in the Department of Psychiatry, College of Medicine, and the Barry and Janet Lang Professor of Integrative Mental Health at the Norton School of Family and Consumer Sciences, College of Agriculture and Life Sciences, University of Arizona. | Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work examining the physical and behavioral effects of compassion training. The recipient of several teaching awards, Dr. Raison has received research funding from the National Institute of Mental Health, National Center for Complementary and Alternative Medicine, and the Centers for Disease Control and Prevention. In 2014 Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association... Read More →
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina | | Vladimir Maletic, MD, MS, is a clinical professor of neuropsychiatry and behavioral science at the U... Read More →


Tuesday September 19, 2017 3:00pm - 4:15pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130

4:15pm

Psych Congress 2017: Final Thoughts and Panel Discussion

Join Psych Congress 2017 Co-Chairs Drs. Rakesh Jain and Charles Raison, and the entire Steering Committee, for an interactive “wrap up” and panel discussion, focusing on conference highlights from the previous four days of educational sessions. 


Tuesday September 19, 2017 4:15pm - 4:30pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130